Upon activation, human peripheral Vγ9Vδ2 T cells also can express IL-4, IL-10, and TGF-β and inhibit T cell proliferation, thus developing a regulatory profile that may play a role in the suppression of anti-tumor responses (130). The gene discussed is TGFB1; the disease is neoplasm.